Sympathetic nervous system thermogenesis pathway

The **sympathetic nervous system thermogenesis pathway** refers to the network of neural circuits and peripheral effectors that regulate heat production—primarily through brown adipose tissue (BAT)—in response to cold exposure, overfeeding, or other metabolic cues. This process is centrally coordinated by brain regions including the hypothalamus and brainstem, which modulate sympathetic outflow via premotor neurons in areas such as the raphe pallidus. The efferent sympathetic nerves innervate BAT and stimulate non-shivering thermogenesis mainly through activation of β-adrenoceptors on brown adipocytes. This leads to increased expression and activity of uncoupling protein 1 (UCP1), resulting in mitochondrial heat production rather than ATP synthesis[1][2]. The same pathways are implicated in adaptive responses during caloric restriction or high-fat diet intake. This entry does **not represent a single molecular target** but rather an integrated physiological process involving multiple cell types, neurotransmitters, receptors, and tissues. As such, it cannot be classified as a therapeutic target like an enzyme or receptor would be. However, individual molecular components within this system—such as β3-adrenoceptor—are considered drug targets for obesity and metabolic diseases[5]. There is something incorrect about using "Sympathetic nervous system thermogenesis pathway" as a druggable target name because it describes an entire regulatory axis rather than one discrete molecule or protein suitable for pharmacological targeting. Key references support that this term encompasses central neural circuits controlling BAT function via sympathetic outflow but do not identify it as a singular molecular entity amenable to direct drug action[1][2][3].

Other names

Sympathetic thermogenic pathwaySNS-mediated thermogenesisCentral BAT thermogenic pathway